Wolverine Trading’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.04M | Buy |
+14,900
| New | +$4.07M | ﹤0.01% | 1559 |
|
|
2025
Q1 | – | Sell |
-16,900
| Closed | -$3.88M | – | 5649 |
|
|
2024
Q4 | $3.88M | Sell |
16,900
-1,200
| -7% | -$289K | ﹤0.01% | 1394 |
|
|
2024
Q3 | $4.33M | Sell |
18,100
-18,100
| -50% | -$4.04M | ﹤0.01% | 1141 |
|
|
2024
Q2 | $6.93M | Buy |
36,200
+4,800
| +15% | +$974K | 0.01% | 802 |
|
|
2024
Q1 | $6.22M | Buy |
31,400
+16,400
| +109% | +$3.01M | 0.01% | 877 |
|
|
2023
Q4 | $2.58M | Sell |
15,000
-11,000
| -42% | -$1.69M | ﹤0.01% | 1532 |
|
|
2023
Q3 | $3.84M | Buy |
26,000
+14,500
| +126% | +$2.62M | ﹤0.01% | 1152 |
|
|
2023
Q2 | $2.49M | Buy |
11,500
+2,000
| +21% | +$446K | ﹤0.01% | 1356 |
|
|
2023
Q1 | $2.05M | Buy |
+9,500
| New | +$2.06M | ﹤0.01% | 1357 |
|
|
2022
Q4 | – | Sell |
-8,200
| Closed | -$1.79M | – | 4873 |
|
|
2022
Q3 | $1.79M | Buy |
8,200
+5,600
| +215% | +$1.27M | ﹤0.01% | 1495 |
|
|
2022
Q2 | $554K | Buy |
2,600
+600
| +30% | +$128K | ﹤0.01% | 2440 |
|
|
2022
Q1 | $498K | Sell |
2,000
-5,900
| -75% | -$1.43M | ﹤0.01% | 3231 |
|
|
2021
Q4 | $2.07M | Buy |
7,900
+200
| +3% | +$51.9K | ﹤0.01% | 1861 |
|
|
2021
Q3 | $2.04M | Sell |
7,700
-1,400
| -15% | -$383K | ﹤0.01% | 2130 |
|
|
2021
Q2 | $2.24M | Buy |
9,100
+5,600
| +160% | +$1.18M | ﹤0.01% | 1872 |
|
|
2021
Q1 | $663K | Buy |
+3,500
| New | +$702K | ﹤0.01% | 3312 |
|
|
2020
Q4 | – | Sell |
-15,100
| Closed | -$2.61M | – | 5371 |
|
|
2020
Q3 | $2.61M | Buy |
15,100
+6,200
| +70% | +$1.14M | 0.01% | 1276 |
|
|
2020
Q2 | $1.68M | Sell |
8,900
-8,000
| -47% | -$1.31M | ﹤0.01% | 1559 |
|
|
2020
Q1 | $2.61M | Sell |
16,900
-1,000
| -6% | -$159K | 0.01% | 1145 |
|
|
2019
Q4 | $2.77M | Sell |
17,900
-14,100
| -44% | -$2.03M | 0.01% | 1565 |
|
|
2019
Q3 | $4.28M | Buy |
32,000
+15,800
| +98% | +$2.07M | 0.01% | 955 |
|
|
2019
Q2 | $1.98M | Sell |
16,200
-2,100
| -11% | -$233K | 0.01% | 1511 |
|
|
2019
Q1 | $1.9M | Buy |
+18,300
| New | +$1.89M | 0.01% | 1571 |
|
|
2018
Q4 | – | Sell |
-18,200
| Closed | -$2.1M | – | 5192 |
|
|
2018
Q3 | $2.1M | Sell |
18,200
-1,000
| -5% | -$110K | ﹤0.01% | 1628 |
|
|
2018
Q2 | $1.89M | Hold |
19,200
| – | – | ﹤0.01% | 1641 |
|
|
2018
Q1 | $1.89M | Buy |
+19,200
| New | +$1.81M | ﹤0.01% | 1641 |
|
|
2017
Q1 | – | Sell |
-14,400
| Closed | -$894K | – | 4881 |
|
|
2016
Q4 | $894K | Sell |
14,400
-5,700
| -28% | -$349K | ﹤0.01% | 2019 |
|
|
2016
Q3 | $1.29M | Buy |
+20,100
| New | +$1.34M | 0.01% | 1636 |
|
Other funds holding RMD
Wolverine Trading's RMD Position: Q4 2024 in Review
Wolverine Trading sold out of ResMed (RMD) in Q4 2024, closing a stake of 2,350 shares — an estimated $566K sold.
Wolverine Trading first reported a position in RMD in Q2 2017 and held it in 18 quarters. The position peaked at $2.74M in Q2 2021. 871 funds tracked by Wall St. Rank hold RMD as of Q4 2024.
- Wolverine Trading reported no remaining ResMed position as of Q4 2024 after selling out during the quarter.
- Wolverine Trading sold 2,350 ResMed shares in Q4 2024, an estimated $566K.
- Wolverine Trading first reported a position in ResMed in Q2 2017 and held it in 18 quarters.
- Wolverine Trading's ResMed position peaked at $2.74M in Q2 2021.
- 871 funds tracked by Wall St. Rank held ResMed as of Q4 2024.
Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.